{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:44Z","timestamp":1790999744778,"version":"4.1.0"},"reference-count":16,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej26-0008","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:09:38Z","timestamp":1780956578000},"page":"1147-1153","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Cushing\u2019s disease due to postoperative seeding of tumor cells in the sphenoid sinus: a case report with review of the literature"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-1092","authenticated-orcid":false,"given":"Tatsuma","family":"Matsuda","sequence":"first","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan"},{"name":"Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tosaka","sequence":"additional","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, et al. (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9: 847\u2013875.","DOI":"10.1016\/S2213-8587(21)00235-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, et al. (2009) Treatment of pituitary-dependent Cushing\u2019s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab 94: 115\u2013122.","DOI":"10.1210\/jc.2008-1008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Palui R, Sahoo J, Kamalanathan S, Kar SS, Selvarajan S, et al. (2018) Effect of cabergoline monotherapy in Cushing\u2019s disease: an individual participant data meta-analysis. J Endocrinol Invest 41: 1445\u20131455.","DOI":"10.1007\/s40618-018-0936-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ferriere A, Cortet C, Chanson P, Delemer B, Caron P, et al. (2017) Cabergoline for Cushing\u2019s disease: a large retrospective multicenter study. Eur J Endocrinol 176: 305\u2013314.","DOI":"10.1530\/EJE-16-0662"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Daniel E, Aylwin S, Mustafa O, Ball S, Munir A, et al. (2015) Effectiveness of metyrapone in treating Cushing\u2019s syndrome: a retrospective multicenter study in 195 patients. J Clin Endocrinol Metab 100: 4146\u20134154.","DOI":"10.1210\/jc.2015-2616"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Frangou EM, Tynan JR, Robinson CA, Ogieglo LM, Vitali AM (2009) Metastatic craniopharyngioma: case report and literature review. Childs Nerv Syst 25: 1143\u20131147.","DOI":"10.1007\/s00381-009-0917-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Fernandes Cabral DT, Zenonos GA, Fernandez-Miranda JC, Wang EW, Gardner PA (2018) Iatrogenic seeding of skull base chordoma following endoscopic endonasal surgery. J Neurosurg 129: 947\u2013953.","DOI":"10.3171\/2017.6.JNS17111"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Wang XY, Xu SJ, Li XG (2010) Post-operative implantation metastasis of craniopharyngioma: a case report. J Int Med Res 38: 1876\u20131882.","DOI":"10.1177\/147323001003800536"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Volante M, Brizzi MP, Faggiano A, La Rosa S, Rapa I, et al. (2007) Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20: 1172\u20131182.","DOI":"10.1038\/modpathol.3800954"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Casar-Borota O, Burman P, Lopes MB (2025) The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors. Brain Pathol 35: e13302.","DOI":"10.1111\/bpa.13302"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Koetsveld AC, Bartels RH, Wijnberg DS, Hermus AR, Lammens M (2001) Drop metastasis from pituitary adenoma. Case illustration. J Neurosurg 95: 719.","DOI":"10.3171\/jns.2001.95.4.0719"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Al-Tameemi M, Chaplain M, d\u2019Onofrio A (2012) Evasion of tumours from the control of the immune system: consequences of brief encounters. Biol Direct 7: 31.","DOI":"10.1186\/1745-6150-7-31"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kipnis P, Ramanathan D, Hoehn R, Jethwa AR, Karakla DW, et al. (2024) Tumor seeding across specialties: a systematic review. Front Oncol 14: 1464767.","DOI":"10.3389\/fonc.2024.1464767"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Roccaro AM, Sacco A, Purschke WG, Moschetta M, Buchner K, et al. (2014) SDF-1 inhibition targets the bone marrow niche for cancer therapy. Cell Rep 9: 118\u2013128.","DOI":"10.1016\/j.celrep.2014.08.042"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Trivedi T, Pagnotti GM, Guise TA, Mohammad KS (2021) The role of TGF-\u03b2 in bone metastases. Biomolecules 11: 1643.","DOI":"10.3390\/biom11111643"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Perez-Vega C, Ramos-Fresnedo A, Tripathi S, Domingo RA, Ravindran K, et al. (2022) Treatment of recurrent and persistent Cushing\u2019s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis. Pituitary 25: 540\u2013549.","DOI":"10.1007\/s11102-022-01215-1"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/10\/73_EJ26-0008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:37:52Z","timestamp":1790998672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/10\/73_EJ26-0008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej26-0008","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ26-0008"}}